.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Illinois, Remedi has shown a consistent presence in the Tincture & Sublingual category, maintaining a solid third-place ranking from January through April 2025. This stability indicates a strong foothold in this category, despite slight fluctuations in sales figures. On the other hand, their performance in the Concentrates category has seen a positive upward trend, moving from the 18th position in January to the 15th position by April. This improvement, coupled with an increase in sales from March to April, suggests a growing acceptance and potential expansion in this segment.
Conversely, in Massachusetts, Remedi's performance in the Concentrates category has been less favorable. The brand's ranking has gradually declined, slipping from 23rd in January to falling out of the top 30 by April. This downward trajectory highlights a competitive market where Remedi might be struggling to maintain its position. The decrease in sales over these months further reinforces the challenges the brand faces in this category within Massachusetts. These insights suggest that while Remedi is strong in certain markets and categories, it faces significant competition and varying consumer preferences that impact its overall performance.
Competitive Landscape
In the competitive landscape of concentrates in Illinois, Remedi has shown a notable upward trajectory in its rankings from January to April 2025. Starting at 18th place in January, Remedi climbed to 15th by April, indicating a positive trend in market presence. This improvement is significant when compared to competitors like Cresco Labs, which experienced a decline from 10th to 18th place over the same period. Meanwhile, Avexia maintained a steady position at 13th, slightly outperforming Remedi but not showing the same upward momentum. IC Collective also remained stable at 14th place, just ahead of Remedi. The consistent improvement in Remedi's ranking suggests effective strategies in capturing market share, potentially driven by increased consumer preference or successful marketing efforts, positioning them well against competitors in the Illinois concentrates market.
Notable Products
In April 2025, the top-performing product for Remedi was the Indica Rest RSO Dropper (0.5g) in the Concentrates category, maintaining its number one rank with sales of 2932 units. The Indica Relief RSO Syringe (0.5g) also held steady in second place, showing consistent performance across the months. The CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) rose to third place, up from fourth in March 2025. Meanwhile, the CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) improved its position to fourth, having been fifth in February. Notably, the Indica Rest RSO Syringe (0.5g) dropped to fifth place, indicating a decline from its previous third-place ranking in March.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
